Thought leaders from around the world contribute their perspectives on landmark cases, new legislation, and legal perspectives on new technologies, business practices, and civil procedure.
Anastasia M. McCarthy
The new Child Victims Act is expected to have a profound and long-lasting impact on public school systems.
Sean M. Cleary
Cases brought against the manufacturer of goods, following an injury caused by an inherent defect within the good, are not based on a theory of negligence, but on a theory of products liability.
Benjamin H. Whitley
None of these cases were class actions. In fact, they are known in the legal world as mass torts.
Elizabeth S. Fitch and Theodore M. Schaer
Cybersecurity and the Claims and Litigation Management Alliance’s School of Cyber Claims
Sidney F. Ansbacher
New law requires FEMA to audit failed hurricane contracts.
Sean M. Cleary
In the case of tort laws and legal reform, for instance, Trump seems to side with "the little guy.”
The FTC, on Jan. 5, 2017, filed a complaint in the Northern District of California against an IoT device manufacturer and its U.S. subsidiary for failure to take reasonable steps to secure the products that they sell to the United States market.
Lawsuits about a blood-thinning drug that prevents platelets from clumping together now prevents plaintiffs from joining together to bring state law claims against a corporation when not every plaintiff was harmed in that state.
Bernard J. Bobber
The dangerous intersection of racial bigotry and labor law.
Clifford J. Zatz and Josh Thomas Foust
The decision “may make it impossible to bring certain mass actions at all.”
Exchanging information is just the first step when it comes to filing a claim after an accident.
The Burden of Substantiation and Proof in Continental European Civil Procedure and the Taking of Evidence in International Arbitration
Dr. Wolfgang Kühn and Katharina Walter
Civil procedures in Germany are governed by the principles of factual substantiation and burden of proof.
Greenberg and Fisher Phillips make new hires, and Children's Law Center recognizes McDermott Will & Emery.
Peter W. Kryworuk
Whether it be the result of a devastating fire loss, a significant errors and omissions claim, or as a victim of fraudulent activity by a trusted employee, insurance coverage is hugely important.
Chalat Hatten & Banker
Ski area operators and skiers should heed new developments to the Ski Safety Act and the Premises Liability Act.
Sharon D. Stuart
Recent lessons from the Eleventh Circuit.
Nancy S. Shilepsky
Gregory Bubalo and Katherine A. Dunnington
Bristol-Myers Squibb Co. v. Superior Court of California will significantly impact the plaintiffs’ choices of forums for the filing of mass torts actions.
Jeff S. Korek
The dramatic difference between these two states in obtaining the opinion of a qualified medical expert has made it much more difficult for those injured in the state of New Jersey by medical negligence.
How long do patent applications take? Consider what you're filing for, and the strength of your proposal.
Potential risks and legal considerations.
Catherine M. Brennan and Nora R. Udell
The fintech revolution has spurred a host of legal questions concerning online lending. Developments at both the federal and state level are beginning to provide some answers.
Bernt Elsner and Molly Kos
The Austrian Cartel Amendment Act (Kartell- und Wettbewerbsrechts-Änderungsgesetz) 2017 might be put up for its first high-class practicability test sooner than expected.
Jamie L. Graham
Patent law is one more area up for debate with changes coming to the Supreme Court.
Charles F. Seemann III
ERISA plan fiduciaries face new challenges to their decision-making.
Legalist launched a two-week campaign to help consumers sue Equifax—in small claims court.
In Bristol-Myers Squibb Co. v. Superior Court of California, multiple plaintiffs sued Bristol-Myers Squibb Co. (BMS) in a California state court to recover damages allegedly caused by their use of BMS’ anti-clotting drug, Plavix.
Corinne E. Atton and April M. Breyer
The March 2017 statistics issued by PTAB report that across all technologies, all challenged patent claims are found patentable in only 19 percent of inter partes review (IPR) final written decisions.